Barinthus Biotherapeutics PLBRNS
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 15 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, up 1 from Q1 2026. 3 opened new positions and 2 sold out. The largest holders were M&G PLC ($5.2M), HSG Holding Ltd ($938K) and GLR Partners, LLC ($821K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $18K |
| Exits | 2 | $48K |
All 13F filers, Q1 2026 → Q2 2026: 159,183 shares bought and 253,020 shares sold, net −93,837 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| M&G PLC | 0.03% | No change | 5,197,349 | $5.2M |
| HSG Holding Ltd | 0.08% | No change | 1,420,473 | $938K |
| GLR Partners, LLC | 0.38% | No change | 1,243,377 | $821K |
| DC Funds, LP | 33.82% | No change | 642,204 | $424K |
| Rangeley Capital, LLC | 0.12% | Add +16.1% | 185,136 | $122K |
| Johns Hopkins University | 0.01% | No change | 122,237 | $81K |
| Morgan Stanley | 0.00% | Add +4825.0% | 108,843 | $72K |
| Baird Financial Group, Inc. | 0.00% | No change | 105,961 | $70K |
| Citadel Advisors | 0.00% | Reduce -35.5% | 76,754 | $51K |
| HighTower Advisors, LLC | 0.00% | No change | 37,450 | $25K |
| Renaissance Technologies | 0.00% | Reduce -83.4% | 25,000 | $17K |
| XTX Topco Ltd | 0.00% | New | 14,819 | $10K |
| Rhumbline Advisers | 0.00% | No change | 11,685 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 11,052 | $7K |
| UBS Group AG | 0.00% | New | 1,008 | $665 |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.